Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands

BACKGROUND: Stroke prevention is the main goal of treating patients with atrial fibrillation (AF). Vitamin-K antagonists (VKAs) present an effective treatment in stroke prevention, however, the risk of bleeding and the requirement for regular coagulation monitoring are limiting their use. Apixaban i...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevanović, Jelena, Pompen, Marjolein, Le, Hoa H., Rozenbaum, Mark H., Tieleman, Robert G., Postma, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122386/
https://www.ncbi.nlm.nih.gov/pubmed/25093723
http://dx.doi.org/10.1371/journal.pone.0103974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122386/
https://www.ncbi.nlm.nih.gov/pubmed/25093723
http://dx.doi.org/10.1371/journal.pone.0103974

Ejemplares similares